MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $389,000 | +6.6% | 29,859 | -7.1% | 0.00% | 0.0% |
Q2 2020 | $365,000 | -26.1% | 32,133 | -7.0% | 0.00% | 0.0% |
Q1 2020 | $494,000 | -51.1% | 34,562 | -6.9% | 0.00% | -50.0% |
Q4 2019 | $1,011,000 | +2.1% | 37,142 | +7.4% | 0.00% | -88.2% |
Q3 2019 | $990,000 | -5.6% | 34,583 | -8.4% | 0.02% | -5.6% |
Q2 2019 | $1,049,000 | -32.1% | 37,757 | -18.8% | 0.02% | -35.7% |
Q1 2019 | $1,544,000 | +5.7% | 46,505 | -7.4% | 0.03% | -6.7% |
Q4 2018 | $1,461,000 | -44.9% | 50,234 | -12.9% | 0.03% | -37.5% |
Q3 2018 | $2,653,000 | +0.5% | 57,672 | -18.3% | 0.05% | -4.0% |
Q2 2018 | $2,639,000 | -2.3% | 70,627 | -22.7% | 0.05% | -3.8% |
Q1 2018 | $2,701,000 | -33.5% | 91,396 | -22.8% | 0.05% | -31.6% |
Q4 2017 | $4,064,000 | -25.2% | 118,337 | -21.2% | 0.08% | -27.6% |
Q3 2017 | $5,432,000 | -0.6% | 150,145 | -29.0% | 0.10% | -2.8% |
Q2 2017 | $5,463,000 | +40.7% | 211,405 | +4.5% | 0.11% | +38.5% |
Q1 2017 | $3,882,000 | +28.5% | 202,231 | +11.6% | 0.08% | +25.8% |
Q4 2016 | $3,020,000 | -5.0% | 181,173 | +17.3% | 0.06% | -4.6% |
Q3 2016 | $3,179,000 | -20.9% | 154,436 | +17.6% | 0.06% | -22.6% |
Q2 2016 | $4,018,000 | -15.1% | 131,297 | +3.8% | 0.08% | -31.1% |
Q1 2016 | $4,733,000 | -15.5% | 126,444 | -2.5% | 0.12% | -15.9% |
Q4 2015 | $5,599,000 | +14.8% | 129,732 | -0.3% | 0.14% | +14.2% |
Q3 2015 | $4,879,000 | +4.6% | 130,178 | -5.1% | 0.13% | +0.8% |
Q2 2015 | $4,663,000 | -0.4% | 137,189 | +3.8% | 0.13% | -6.0% |
Q1 2015 | $4,680,000 | +5.5% | 132,192 | +1.5% | 0.13% | +3.1% |
Q4 2014 | $4,436,000 | -14.4% | 130,233 | -3.0% | 0.13% | -17.2% |
Q3 2014 | $5,181,000 | -7.0% | 134,320 | -6.1% | 0.16% | -6.0% |
Q2 2014 | $5,568,000 | +11.0% | 143,068 | -2.5% | 0.17% | +5.7% |
Q1 2014 | $5,015,000 | +61.9% | 146,697 | -0.7% | 0.16% | +58.0% |
Q4 2013 | $3,098,000 | -6.3% | 147,669 | +4.9% | 0.10% | -14.5% |
Q3 2013 | $3,306,000 | +5.4% | 140,719 | +20.5% | 0.12% | 0.0% |
Q2 2013 | $3,138,000 | – | 116,777 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |